- Home
- Safety Centre
- Fake weight-loss pens
Fake weight-loss pens (UK)
Counterfeit and contaminated injectable weight-loss pens — copies of Ozempic, Wegovy, Mounjaro and Saxenda — are an active UK safety issue. The MHRA has issued warnings; people have been hospitalised. This is what to look for, what to do, and how to report.
Why this matters
Demand for GLP-1 receptor agonists like semaglutide and tirzepatide has driven a significant black market in counterfeit and re-filled pens, sold via social media, messaging apps, and unregulated websites. Some seized products have contained the wrong active ingredient (including insulin), incorrect concentrations, or no active ingredient at all. UK patients have been hospitalised, including with severe hypoglycaemia.
The lawful route in the UK is a prescription from a registered prescriber, dispensed by a regulated pharmacy. See prescription-only medicines and how to check a UK pharmacy.
Warning signs a pen may be counterfeit
- It was purchased without a prescription, or with a “light-touch” online questionnaire and no clinician interaction.
- It was bought via Instagram, TikTok, WhatsApp, Telegram, or a Facebook Marketplace style listing.
- The price is significantly below standard UK private prescription pricing.
- The packaging or labelling has spelling errors, the wrong language, missing batch numbers, missing UK marketing authorisation holder details, or a non-UK Patient Information Leaflet.
- The pen looks superficially correct but the dose-selection mechanism feels different or clicks differently.
- Seller is unwilling or unable to identify themselves and provide a regulated pharmacy registration.
- Product was “imported privately” or arrived without UK pharmacy documentation.
- The seller advises you not to report any side effects.
If you think a pen is counterfeit
- Stop using it. Do not take another dose to “see what happens.”
- Seek medical advice. Call NHS 111 for urgent but non-emergency advice, or 999 in an emergency.
- Do not throw it away yet. The product, packaging, and any communication with the seller may be needed by the MHRA.
- Report to the MHRA Yellow Card scheme and the MHRA's separate reporting route for suspected counterfeit medicines.
- Report to Action Fraud if you have been scammed.
What a legitimate UK route looks like
- A consultation with a registered UK prescriber (GP, specialist, or appropriately registered private prescriber).
- A prescription dispensed by a UK-regulated pharmacy listed on the GPhC (England, Scotland, Wales) or PSNI (Northern Ireland) register.
- Genuine UK packaging including a Patient Information Leaflet, batch number, expiry date, MAH details, and a pharmacy label.
- Ongoing clinical contact for side-effect monitoring.
Red-flag seller language
If you see wording like this on a seller, clinic, or social-media advert, treat it as a warning sign rather than a benefit.
“No prescription needed — fast UK delivery”
Semaglutide, tirzepatide, liraglutide are UK prescription-only medicines. A seller offering them without a valid prescription is operating outside UK law and outside the pharmacy regulator's framework.
“Genuine pens, half the price of clinics”
Authentic UK supply has fixed wholesale costs and shortages have pushed prices up, not down. Cut-price genuine product is implausible.
“Discreet shipping, plain packaging”
Suggests the seller wants the consignment to avoid pharmacy and customs scrutiny — the opposite of a regulated supply chain.
“We test our products in-house — fully safe”
In-house testing by an unregulated seller is not independent verification. Real UK pharmacy supply uses authorised channels, not bench testing.
“Imported from EU pharmacies, same product”
Even legitimate EU product needs lawful UK import and supply. Many such listings are not, in fact, genuine EU pharmacy product.
Questions to ask a UK pharmacist or prescriber
These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.
- How can I confirm this prescription was dispensed by a UK-registered pharmacy?
- What is the pharmacy's GPhC or PSNI registration number?
- What should the genuine packaging and PIL for this product look like?
- If I have a pen from an unregulated source, what's the safest way to dispose of it?
- How do I report a suspected counterfeit to the MHRA?
- What side effects should make me seek immediate medical attention?
- Is there an NHS access route to a GLP-1 medicine for my situation?
Primary sources
- MHRA — Medicines and Healthcare products Regulatory Agency — gov.uk
UK regulator. Source for Drug Safety Updates and counterfeit-medicine warnings.
- MHRA Yellow Card — report suspected side effects and counterfeits — yellowcard.mhra.gov.uk
- MHRA Drug Safety Update (publication landing) — gov.uk
Filter by therapeutic area for the specific GLP-1 / counterfeit pen alert.
- Action Fraud (UK) — actionfraud.police.uk
- GPhC pharmacy register — pharmacyregulation.org
- PSNI Northern Ireland pharmacy register — psni.org.uk